Fighting for victims of Drug-Coated Stents
Email this page to a friend Print this page

WWW.FINZFIRM.COM
1-888-FINZFIRM
1-888-346-9347
Finz & Finz, P.C.
Attorneys And Counselors At Law

New York Defective Medical Product Lawyer

J&J will pull drug-coated stent off market

May 8, 2007 | Associated Press | CapeCodTimes.com
NEW YORK - Conor Medsystems, a maker of heart stents recently acquired by Johnson & Johnson Inc., said yesterday its CoStar drug-infused stent failed in a clinical trial against Boston Scientific's Taxus Express drug-coated stent...
FULL STORY

Can Drug-Coated Stents Beat Bypass?

Apr 27, 2007 | Daniel J. DeNoon | WebMD Medical News
April 19, 2007 - Complications and three-year survival rates are similar for heart patients treated with drug-coated stents and those treated with bypass surgery, a new study shows...
FULL STORY

Boston Scientific profit plunges on Guidant costs, sagging stent sales

Apr 23, 2007 | Associated Press | Herald Tribune
BOSTON: Boston Scientific Corp. on Monday said its first-quarter profit fell by 64 percent on weak sales of the medical device...
FULL STORY

Can Drug-Coated Stents Beat Bypass?

Apr 19, 2007 | Staff | WebMD
(WebMD) Complications and three-year survival rates are similar for heart patients treated with drug-coated stents and those treated with bypass surgery, a new study shows...
FULL STORY

Market Share Slips for Drug-Coated Stents

Apr 11, 2007 | Keith J. Winstein | WSJ.com
The market share for drug-coated coronary stents slipped to 70.1% in February, marking the sixth straight month of decline, according to a survey by a market-research firm that surveys U.S. hospitals...
FULL STORY

Analysts: Stent study shouldn't impact market long-term

Mar 27, 2007 | Val Brickates Kennedy | Market Watch
BOSTON (MarketWatch) -- Analysts said Tuesday that they don't expect a long-term impact on stent sales from the recent release of a major study...
FULL STORY

Stent study sends Abbott stock to record

Mar 27, 2007 | Staff | Chicago SunTimes
Abbott Laboratories shares shot to an all-time high Monday after a study showed its Xience drug-coated heart stent was superior to Boston Scientific's Taxus drug-coated stent...
FULL STORY

Studies Highlight Pitfalls of Drug-Coated Stents

Mar 26, 2007 | Staff | Forbes.com
MONDAY, March 26 (HealthDay News) -- About a third of patients who receive artery-opening drug-coated stents aren't taking the anticlotting drug doctors often prescribe to keep the stent functioning as it should, a new U.S. study finds...
FULL STORY

Study expected to hit sales of drug-coated stents

Mar 24, 2007 | Associated Press | Boston.com
Wall Street analysts and many doctors expect another potential setback for stent makers when results of a blockbuster study...
FULL STORY

Medicare Might Expand Coverage for Expensive Carotid Artery Disease Treatment

Mar 23, 2007 | Staff | Henry J. Kaiser Family Foundation
CMS by May plans to decide whether to expand Medicare coverage for an expensive procedure to treat carotid artery disease, which occurs when major art...
FULL STORY
More Drug-Coated Stent News...
1 2 3 4 5 [6] 7 8

(required) Denotes required field


Title


(required) First Name


(required) Last Name


(required) Phone Number


Email Address


Address


City


(required) State


Zip Code


Best Way/Time to Contact You


Injured Person's Name


Injured Person's Date of Birth
(mm/dd/yyyy)

Date of Incident
(mm/dd/yyyy)

Type of Incident


Please Describe the Incident


Please sign me up for the Finz & Finz, P.C. Newsletter


I agree to the Finz & Finz, P.C. Terms of Use